🇺🇸 FDA
Patent

US 9771338

1,2,4-oxadiazole derivatives as immunomodulators

granted A61KA61K31/395A61K31/4245

Quick answer

US patent 9771338 (1,2,4-oxadiazole derivatives as immunomodulators) held by Auirgene Discovery Technologies Limited expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Auirgene Discovery Technologies Limited
Grant date
Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/395, A61K31/4245, A61K31/433, A61K45/06